Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus
- PMID: 26973295
- PMCID: PMC4854533
- DOI: 10.1016/j.meegid.2016.03.010
Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus
Abstract
A human infection with novel avian influenza A H5N6 virus emerged in Changsha city, China in February, 2014. This is the first detected human case among all human cases identified from 2014 to early 2016. We obtained and summarized clinical, epidemiological, and virological data from this patient. Complete genome of the virus was determined and compared to other avian influenza viruses via the construction of phylogenetic trees using the neighbor-joining approach. A girl aged five and half years developed fever and mild respiratory symptoms on Feb. 16, 2014 and visited hospital on Feb. 17. Throat swab specimens were obtained from the patient and a novel reassortant avian influenza A H5N6 virus was detected. All eight viral gene segments were of avian origin. The hemagglutinin (HA) and neuraminidase (NA) gene segments were closely related to A/duck/Sichuan/NCXN11/2014(H5N1) and A/chicken/Jiangxi/12782/2014(H10N6) viruses, respectively. The six internal genes were homologous to avian influenza A (H5N2) viruses isolated in duck from Jiangxi in China. This H5N6 virus has not gained genetic mutations necessary for human infection and was suggested to be sensitive to neuraminidase inhibitors, but resistant to adamantanes. Epidemiological investigation of the exposure history of the patient found that a live poultry market could be the source place of infection and the incubation period was 2-5days. This novel reassortant Avian influenza A(H5N6) virus could be low pathogenic in humans. The prevalence and genetic evolution of this virus should be closely monitored.
Keywords: Avian influenza; H5N6; Reassortant; Sequence; The first detected human case.
Copyright © 2016 Elsevier B.V. All rights reserved.
Figures
References
-
- Chen HY, Yuan H, Gao RB, Zhang JX, Wang DY, Xiong Y, Fan GY, Yang F, Li XD, Zhou JF, Zou SM, Yang L, Chen T, Dong LB, Bo H, Zhao X, Zhang Y, Lan Y, Bai T, Dong J, Li Q, Wang SW, Zhang YP, Li H, Gong T, Shi Y, Ni XS, Li JX, Zhou J, Fan JY, Wu JW, Zhou XF, Hu MH, Wan JG, Yang WZ, Li DX, Wu GZ, Feng ZJ, Gao GF, Wang Y, Jin Q, Liu MB, Shu YL. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet. 2014;383:714–721. - PubMed
-
- Cheng VCC, Chan JFW, Wen X, Wu WL, Que TL, Chen H, Chan KH, Yuen KY. Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect. 2011;62:394–399. - PubMed
-
- Fan SF, Deng GH, Song JS, Tian GB, Suo YB, Jiang YP, Guan YT, Bu ZG, Kawaola Y, Chen HL. Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology. 2009;384:28–32. - PubMed
-
- Gao RB, Cao B, Hu YW, Feng ZJ, Wang DY, Hu WF, Chen J, Jie ZJ, Qiu HB, Xu K, Xu XW, Lu HZ, Zhu WF, Gao ZC, Xiang NJ, Shen YZ, He ZB, Gu Y, Zhang ZY, Yang Y, Zhao X, Zhou L, Li XD, Zou SM, Zhang Y, Li XY, Yang L, Guo JF, Dong J, Li Q, Dong LB, Zhu Y, Bai T, Wang SW, Hao P, Yang WZ, Zhang YP, Han J, Yu HJ, Li DX, Gao GF, Wu GZ, Wang Y, Yuan ZH, Shu YL. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–1897. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
